Last reviewed · How we verify
Prostin E2 Vaginal Suppository
At a glance
| Generic name | Prostin E2 Vaginal Suppository |
|---|---|
| Also known as | Propess |
| Sponsor | St George's, University of London |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mechanical Dilation of the Cervix in a Scarred Uterus (NA)
- Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter (PHASE4)
- Gemeprost Versus Dinoprostone in First Trimester Miscarriages (PHASE2)
- Comparison Between Propess and Cook Double-balloon Catheter for Cervical Priming (PHASE4)
- Foley Catheter Versus PGE2 for Labor Induction at Term: a Pilot Study (PHASE4)
- What After the First Propess (PHASE2)
- Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Multiparous Women at Term (NA)
- Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |